✦ LIBER ✦

Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation

✍ Scribed by Endri Mauro; Gian Matteo Rigolin; Chiara Fraulini; Olga Sofritti; Maria Ciccone; Cristiano De Angeli; Gianluigi Castoldi; Antonio Cuneo

Book ID: 114794164
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 731 KB
Volume: 78
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2007.00831.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mobilization of peripheral blood stem ce

Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex

✍ Cheng Zhang; Xinghua Chen; Xi Zhang; Lei Gao; Peiyan Kong; Qingyu Wang; Xiangui 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Filgrastim, lenograstim and pegfilgrasti

Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies

✍ Ria, Roberto; Reale, Antonia; Melaccio, Assunta; Racanelli, Vito; Dammacco, Fran 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 326 KB

Patterns of recovery phase infection aft

Patterns of recovery phase infection after autologous blood progenitor cell transplantation in patients with malignancies

✍ D. D'Antonio; A. Iacone; L. Pierelli; T. Bonfini 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 536 KB

Patients with hematological malignancies

Patients with hematological malignancies experience a higher rate of documented infections than patients with solid tumors after high-dose chemotherapy with autologous peripheral stem cell transplantation

✍ Sezer, O.; Späth-Schwalbe, E.; Fuss, H.; Eucker, J.; Bauhuis, C.; Kobert, U.; He 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

EPO in combination with G-CSF improves m

EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells

✍ Hart, C; Grassinger, J; Andreesen, R; Hennemann, B 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

Safety and efficacy of high-dose chemoth

Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas

✍ Benjamin Chen; Tauseef Ahmed; Anney Mannancheril; Michael Gruber; Deborah L. Ben 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Malignant astrocytomas are among the most resistant tumors to curative treatments. Mean survival without treatment is measured in weeks, and even with maximal surgery and radiation, the mean reported survival is < 1 year. The advent of supportive treatments and newer agen